Overview
Trains clinician-researchers in personalised cancer therapy, early-phase clinical trials and drug development.
The programme
- Training type
- Clinical Fellowship
- Duration
- 1 or 2 years
- Start
- 1 July
- Positions
- Not stated on official page
- Accreditation
- MD Anderson GME programme (non-ACGME)
- Department
- Department of Investigational Cancer Therapeutics
Eligibility and visa
- Eligibility
- Completed haematology/oncology or medical oncology fellowship (US, Canada or foreign equivalent); eligible for Texas physician-in-training permit or licence; interest in drug development
- International applicants
- IMGs eligible with valid ECFMG certificate and USMLE Step 1 and Step 2 CK (each passed within 3 attempts) (MD Anderson GME eligibility page)
- Visa support
- J-1 visa (ECFMG-sponsored) is the required visa for international trainees needing sponsorship; H-1B not offered (MD Anderson GME eligibility page)
- Licence requirement
- Texas Medical Board physician-in-training permit or Texas medical licence
How to apply
- Deadline
- Applications open 1 July and close 30 September; interviews October-November
- Application method
- Online application via programme page
Funding
- Funding
- Not stated on official page
Official sources
https://www.mdanderson.org/education-training/clinical-training/graduate-medical-education/residencies-fellowships/investigational-cancer-therapeutics.htmlhttps://www.mdanderson.org/education-training/clinical-training/graduate-medical-education/residencies-fellowships/investigational-cancer-therapeutics/fellowship-details-requirements.htmlhttps://www.mdanderson.org/education-training/clinical-training/graduate-medical-education/gme-trainee-resources/eligibility-requirements.html